Introduction

Tillotts is a leading international specialty pharmaceutical company with an established presence in Europe and in the rest of the world. Tillotts markets its first-line products, such as Asacolon®, Entocort®, and DIFICLIR in over 65 countries through its own affiliates within Europe and a network of gastroenterology-focused marketing partners throughout the world. Information placed on this website is not intended as a substitute for consultation with your healthcare professional. Please consult your healthcare professional for further information
Asacolon®

Asacolon®

Information placed on this website is not intended as a substitute for consultation with your healthcare professional. Please consult your healthcare profession[...] Read more »
DIFICLIR™

DIFICLIR™

Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your healthcare p[...] Read more »
Entocort®

Entocort®

Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your healthcare p[...] Read more »
Last update: November 2023
All trademarks used or mentioned here are protected by law. Tillotts Pharma AG’s trademarks include Tillotts®, Asacol™, OPTICORE™, Octasa™, Fivasa™, Yaldigo™, Kiudro™, Lixacol™, Asacolon™, Colpermin™, VistaPrep™, Entocort™, Entocir™, Entocord™, Budecol™ and DIFICLIR™ are either registered or applied for in around 65 countries (transfer of registrations to Tillotts pending in certain countries). The rights to Asacol, including the rights to the trademark, are owned by Tillotts in various countries except for the following: Switzerland, USA, United Kingdom, Canada, Italy, Belgium, the Netherlands and Luxembourg. The product rights to Asacol 1600 mg are owned by Tillotts globally, with the trademark varying from country to country. OPTICORE™ has been developed based on the Phloral™ technology.